Reporter

Jacek Hawiger, MD, PhD, third from right, with study team members, from left, Katherine Gibson-Corley, DVM, PhD, Yan Liu, MD, Jozef Zienkiewicz, PhD, Huan Qiao, MD, PhD, and Ruth Ann Veach.
November 10, 2022

Hawiger still blazing a trail in inflammation research

Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.

By Bill Snyder
After two surgeries to remove tumors from her spine, patient Reagan Brown can walk freely again and has no limitations.
November 10, 2022

Spinal surgeries help restore young patient’s mobility

By Nancy Humphrey
The clinical trial group includes, from left, Gordon Bernard, MD, Katherine Cahill, MD, Kevin Niswender, MD, PhD, Pingsheng Wu, PhD, and R. Stokes Peebles, MD.
November 10, 2022

Clinical trial at VUMC tests novel treatment for asthma

VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

By Leigh MacMillan
November 10, 2022

Study explores CVD risk for people with HIV

A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.

By Matt Batcheldor
November 10, 2022

Study defines role of steroids in congenital heart disease surgery

Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.

By Bill Snyder
November 10, 2022

Kennedy Center seeks participants for disabilities research learning sessions

In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

By Paul Govern
November 10, 2022

Infectious Diseases Society of America honors Wright

Vanderbilt's Patty Wright, MD, is one of two recipients of the 2022 Watanakunakorn Clinician Award from the Infectious Diseases Society of America.
By Paul Govern
November 10, 2022

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.
By Nancy Humphrey
November 10, 2022

Child passenger safety program receives funding from GM

The Stay Seat Smart Program at Monroe Carell Jr. Children's Hospital at Vanderbilt recently received funding from General Motors to address child safety seat misuse through education, community outreach and media awareness.
By Jessica Pasley
November 10, 2022

Elam Lecture

Tracy Gaudet, MD, recently delivered the third annual Dr. Roy O. Elam Memorial Lecture sponsored by the Osher Center for Integrative Medicine at Vanderbilt, the Department of Physical Medicine and Rehabilitation and the Vanderbilt Center for Musculoskeletal Research.
By VUMC News and Communications
November 8, 2022

Alzheimer’s risk factor and cognition

Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.
By Leigh MacMillan
November 7, 2022

Gene mutations impair gut barrier

Mutations in a cell membrane transporter protein impair the integrity of the gut lining, contributing to chronic gastrointestinal distress for people with the mutations, Vanderbilt researchers report.
By Kelsey Pinckard
November 4, 2022

Study finds Moderna’s COVID-19 vaccine safe and effective for young children

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
By Bill Snyder
1 … 62 63 64 65 66 … 725